Search

Your search keyword '"Iannone, Valentina"' showing total 20 results
Start Over Author "Iannone, Valentina"
20 results on '"Iannone, Valentina"'

2. HIV and vicarious stigma in a cohort of people living with HIV in Italy: What happens when the stigma is fueled by healthcare providers?

Author

Massaroni, Valentina, primary, Iannone, Valentina, additional, Donne, Valentina Delle, additional, D’Angelillo, Anna, additional, Baldin, Gianmaria, additional, Passerotto, Rosanna, additional, Sangiorgi, Flavio, additional, Steiner, Rebecca Jo, additional, Ciccullo, Arturo, additional, Borghetti, Alberto, additional, Visconti, Elena, additional, and Giambenedetto, Simona Di, additional

Published
2024
Full Text
View/download PDF

4. Characteristics of mental health interventions in a cohort of Italian PLWH over the last five years: impact of HIV disease and outbreak of COVID-19 pandemic

Author

Delle Donne, Valentina, primary, Massaroni, Valentina, additional, Borghetti, Alberto, additional, Ciccullo, Arturo, additional, Dusina, Alex, additional, Lombardi, Francesca, additional, Steiner, Rebecca Jo, additional, Iannone, Valentina, additional, Salvo, Pierluigi Francesco, additional, and Di Giambenedetto, Simona, additional

Published
2023
Full Text
View/download PDF

5. Are we really ready for dual therapy in naive people with HIV? The experience from a large university hospital in Rome, Italy.

Author

Salvo, Pierluigi Francesco, Ciccullo, Arturo, Iannone, Valentina, Steiner, Rebecca Jo, Lamanna, Francesco, Passerotto, Rosa Anna, Carbone, Andrea, Borghetti, Alberto, Giambenedetto, Simona Di, and Baldin, Gianmaria

Subjects
HIV, HIV-positive persons, UNIVERSITY hospitals, HIV prevention
Abstract

This article discusses the use of a two-drug antiretroviral therapy (ART) regimen for treatment-naive individuals living with HIV. The authors highlight the hesitation among clinicians to prescribe this regimen, despite its efficacy and potential benefits. The study conducted at a university hospital in Rome, Italy, analyzed the outcomes of patients who met the criteria for initiating a two-drug regimen with lamivudine/dolutegravir. The results showed that the two-drug regimen was well-tolerated and had comparable virological efficacy to a three-drug regimen. Additionally, the two-drug regimen had a lower rate of treatment discontinuation and a higher probability of maintaining the first-line regimen. The authors emphasize the importance of bridging the gap between guidelines and clinical practice to increase the prescription rate of the two-drug regimen. [Extracted from the article]

Published
2024
Full Text
View/download PDF

6. Changes in Metabolic Profile in PLWHIV Switching to Doravirine-Based Regimen

Author

Iannone, Valentina, primary, Passerotto, Rosa Anna, additional, Lamanna, Francesco, additional, Steiner, Rebecca Jo, additional, Lombardi, Francesca, additional, Salvo, Pierluigi Francesco, additional, Dusina, Alex, additional, Farinacci, Damiano, additional, Borghetti, Alberto, additional, Di Giambenedetto, Simona, additional, and Ciccullo, Arturo, additional

Published
2023
Full Text
View/download PDF

8. Liver fibrosis may lower PSA levels: A further reason to be wary in prostate cancer screening in men with HIV?

Author

Mazzitelli, Maria, primary, Foca', Emanuele, additional, Prosperi, Mattia, additional, Cauda, Roberto, additional, Farinacci, Damiano, additional, Iannone, Valentina, additional, Castelli, Francesco, additional, Carriero, Canio, additional, Pan, Angelo, additional, Saracino, Annalisa, additional, Torti, Carlo, additional, and Quiros‐Roldan, Eugenia, additional

Published
2023
Full Text
View/download PDF

10. Cardiovascular Disease Risk in a Cohort of Virologically Suppressed People Living with HIV Switching to Doravirine: Preliminary Data from the Real Life

Author

Iannone, Valentina, primary, Farinacci, Damiano, additional, D'Angelillo, Anna, additional, Dusina, Alex, additional, Lamanna, Francesco, additional, Passerotto, Rosanna, additional, Baldin, Gianmaria, additional, Visconti, Elena, additional, Tamburrini, Enrica, additional, Borghetti, Alberto, additional, Di Giambenedetto, Simona, additional, and Ciccullo, Arturo, additional

Published
2022
Full Text
View/download PDF

12. Are we ready for long‐acting? A feasibility evaluation of long‐acting cabotegravir–rilpivirine in clinical practice

Author

Borghetti, Alberto, primary, Farinacci, Damiano, additional, Ciccullo, Arturo, additional, Dusina, Alex, additional, Moschese, Davide, additional, Iannone, Valentina, additional, D'Angelillo, Anna, additional, Lombardi, Francesca, additional, Donne, Valentina Delle, additional, Massaroni, Valentina, additional, Visconti, Elena, additional, Tamburrini, Enrica, additional, and Di Giambenedetto, Simona, additional

Published
2022
Full Text
View/download PDF

18. Reporting a single case of cystic echinococcosis in retroperitoneal mass of uncertain origin.

Author

Di Giambenedetto S, Fagotti A, Quaranta G, Iannone V, Fancello G, Steiner RJ, Mazzon G, Masucci L, Teodorico E, Borghetti A, Naldini A, and Scambia G

Subjects
Animals, Humans, Albendazole therapeutic use, Risk Factors, Echinococcosis diagnosis, Echinococcosis drug therapy, Echinococcosis surgery, Echinococcus, Echinococcus granulosus
Abstract

Echinococcal disease (hydatid disease (HD) is an endemic parasitosis caused by Echinococcus granulosus in the larval stage, and it is typically due to the production of unilocular cystic lesions, usually involving the liver for the majority of patients and the lungs in 25%, but also any other organs can be potentially involved in developing echinococcal disease. We report a case of extrahepatic, retroperitoneal echinococcal disease, caused by Echinococcus granulosus. The patient underwent a surgical removal of the abdominal mass, revealed by abdominal ultrasound and computerized tomography scanning, and in the founded clinical and radiological suspicion of echinococcal disease, multiple bioptical samples were sent for microbiological analysis and albendazole therapy was started; Echinococcus granulosus protoscolices were found on the bioptical sample, and the diagnosis was successfully confirmed. According to the current parasitology literature on echinococcal disease, extrahepatic localization, although rare, can be found, and it should be considered in the differential diagnosis of an abdominal mass when epidemiological risk factors and anamnestic data are present, regardless of the usual site of the disease., (© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)

Published
2023
Full Text
View/download PDF

19. Toxoplasmosis mimicking CMV chorioretinitis in newly diagnosed PLWH: a case report.

Author

Lamanna F, Passerotto RA, Carbone A, Steiner RJ, Iannone V, Salvo PF, Ciccullo A, Baldin G, Borghetti A, and Dusina A

Abstract

Background: cytomegalovirus (CMV) retinitis, cerebral and ocular toxoplasmosis are common infections in patients with acquired immunodeficiency syndrome (AIDS). Material and methods: this is a case of a 46-year-old female with previous Kaposi's sarcoma, diagnosed with an HIV infection two weeks prior to hospitalization. Blood test at diagnosis showed a CD4+ count of 77 cell/μL and HIV-RNA 3.758.745 copies/mL. Therapy with bictegravir/emtricitabine/tenofovir alafenamide fumarate was started and clinical, viroimmunological and microbiological investigations were performed., Results: the patient went to our hospital for the onset of left occipito-parietal headache and blurred vision. Brain CT and MRI were performed which did not show focal lesions or vascular alterations. Syphilis serology was negative, Toxoplasma gondii serology showed positive IgG and negative IgM, serum CMV-DNA was 31.184 IU/mL. Eye fundus evidenced intraretinal hemorrhages, fluorescein angiography and computed optical tomography documented cottony exudates, retinal hemorrhages and vitreous involvement. Therapy with valganciclovir was initiated for suspicion of CMV retinitis. About a month later, the patient reported blurred vision for which she was re-admitted. Ocular fundus showed a cottony lesion near the macula. Molecular test on vitreous body was positive for Toxoplasma gondii , while on cerebrospinal fluid it was negative; in addition, an MRI of the brain with contrast medium was performed which showed an area of altered hyperintense signal compatible with a diagnosis of Toxoplasma gondii uveitis and neurotoxoplasmosis. Therapy with pyrimethamine and clindamycin (allergy for sulfonamide reported by the patient) was started. Allergy counseling was performed with the execution of allergy tests (patch test) with negative result; therefore the administration of clindamycin was replaced with sulfadiazine. A month following the start of anti-toxoplasma therapy, there was a clinical and radiological improvement., Conclusions: despite progressive developments in the management of PLWH, in this case two different kind of opportunistic infection are found in a late-presenter patient. In particular, two aspects can be highlighted. The first one is that, in the setting of an highly impaired immune system, clinical presentation can be deceptive and more than one opportunistic infection can be observed together in the same patient. The second aspect is that after starting antiretroviral therapy, a rapid improvement of viro-immunologic parameters has been documented, probably leading to an immune reconstitution inflammatory syndrome (IRIS)., Competing Interests: Conflicts of interest A.C. received support for travel to meetings from ViiV Healthcare, A.B. received speakers’ honoraria from ViiV Healthcare, and fees for attending advisory boards from Janssen-Cilag. S.D.G. was a paid consultant or member of advisory boards for Gilead Sciences, ViiV Healthcare, Janssen-Cilag, Merck Sharp & Dohme and Bristol-Myers Squibb. All other authors: none to declare.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results